Savoye et al. performed a retrospective analysis to assess early outcomes of kidney transplants in the French controlled donation after circulatory death (cDCD) program by comparing them to transplants from donation after brain death (DBD) donors in the French National cohort.
The French cDCD protocol has three main characteristics: the use of normothermic regional perfusion (NRP) and hypothermic machine perfusion (HMP) while attempting to keep the cold ischemic time as short as possible. They included 499 cDCD and 6,185 DBD transplantations in the full cohort, and the matched cohort included 442 cDCD and 809 DBD transplants.
They found that:
- The cDCD group had less DGF than the DBD group
- Although slightly fewer graft failures in the cDCD group (5.0% vs 6.1%), it did not reach statistical significance
- They found that the risk of DGF among DBD transplants was lower when hypothermic machine perfusion was used
Overall, the early outcomes for the French cDCD program were similar or better than comparable DBD transplants.
Read the full article here: https://doi.org/10.1111/ajt.16425
Check out the most recent posts
David’s Transplant Journey
In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...
Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study
We are proud to announce that the first livers have officially been transplanted using the LifePort®Liver Transporter as part of the PILOT™ Continued Access Study. The first livers preserved with the LLT under Continued Access were transplanted at University...